TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer
June 24, 2026
TRAIL-R2 is also a key mediator of apoptosis but its clinical implications and epigenetic regulation in breast cancer are not clearly understood.”BUFFALO, NY - June 24, 2026 – A new research... read more
